Cannabis Investing Valens Announces Revenue Guidance for Fourth Quarter 2019 and Intention to Commence a Normal Course Issuer Bid
Cannabis Investing Valens Establishes Operations in the Greater Toronto Area with the Acquisition of a Leading Beverage Company
Cannabis Investing Valens and BRNT Enter into Major White Label Deal with a Gross Revenue Potential to Valens of More Than $50 Million
Cannabis Investing Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019
Cannabis Investing Valens to Hold Conference Call to Discuss Financial Results for the Third Quarter of Fiscal 2019
Cannabis Investing Valens Receives Amended License from Health Canada Permitting Sales Directly to Provinces and Territories & Provides Operational Update
Cannabis Investing Valens Becomes First Third Party Processor to Enter Strategic Agreement with Shoppers Drug Mart to Supply Cannabis Oil Products
Cannabis Investing Valens Announces 5 Year White Label Cannabis Infused Beverage Contract with Iconic Brewing Company’s Cannabis Division
Cannabis Investing Valens Announces Guidance for Record Q3 2019 Revenue and Participation in Live Investor Webcast on September 12th
